Johnson and Johnson 2009 Annual Report Download - page 57

N O T E S T O C O N S O L I D A T E D F I N A N C I A L S T A T E M E N T S 55
18. Segments of Business(1) and Geographic Areas
Sales to Customers(2)
____________________________________
(Dollars in Millions) 2009 2008 2007
Consumer —
United States $ 6,837 6,937 6,408
International 8,966 9,117 8,085
Total 15,803 16,054 14,493
Pharmaceutical —
United States 13,041 14,831 15,603
International 9,479 9,736 9,263
Total 22,520 24,567 24,866
Medical Devices and Diagnostics —
United States 11,011 10,541 10,433
International 12,563 12,585 11,303
Total 23,574 23,126 21,736
Worldwide total $61,897 63,747 61,095
Operating Profit Identifiable Assets
____________________________________ ____________________________________
(Dollars in Millions) 2009(5) 2008(6) 2007(7) 2009 2008 2007
Consumer $ 2,475 2,674 2,277 $24,671 23,765 26,550
Pharmaceutical 6,413 7,605 6,540 21,460 19,544 19,780
Medical Devices and Diagnostics 7,694 7,223 4,846 22,853 20,779 19,978
Total 16,582 17,502 13,663 68,984 64,088 66,308
Less: Expense not allocated to segments(3) 827 573 380
General corporate(4) 25,698 20,824 14,646
Worldwide total $15,755 16,929 13,283 $94,682 84,912 80,954
Additions to Property, Depreciation and
Plant & Equipment Amortization
____________________________________ ____________________________________
(Dollars in Millions) 2009 2008 2007 2009 2008 2007
Consumer $ 439 499 504 $513 489 472
Pharmaceutical 535 920 1,137 922 986 1,033
Medical Devices and Diagnostics 1,114 1,251 919 1,124 1,146 1,080
Segments total 2,088 2,670 2,560 2,559 2,621 2,585
General corporate 277 396 382 215 211 192
Worldwide total $2,365 3,066 2,942 $2,774 2,832 2,777
Sales to Customers(2) Long-Lived Assets(8)
____________________________________ ____________________________________
(Dollars in Millions) 2009 2008 2007 2009 2008 2007
United States $30,889 32,309 32,444 $22,399 21,674 21,685
Europe 15,934 16,782 15,644 17,347 14,375 15,578
Western Hemisphere excluding U.S. 5,156 5,173 4,681 3,540 3,328 3,722
Asia-Pacific, Africa 9,918 9,483 8,326 1,868 1,898 1,261
Segments total 61,897 63,747 61,095 45,154 41,275 42,246
General corporate 790 785 702
Other non long-lived assets 48,738 42,852 38,006
Worldwide total $61,897 63,747 61,095 $94,682 84,912 80,954
(1) See Note 1 for a description of the segments in which the Company operates.
(2) Export sales are not significant. In 2009, 2008 and 2007, the Company did not have a customer that represented 10% of total revenues.
(3) Amounts not allocated to segments include interest (income) expense, non-controlling interests and general corporate (income) expense.
(4) General corporate includes cash and marketable securities.
(5) Includes $1,186 million of restructuring expense, comprised of $369 million, $496 million, and $321 million for the Consumer, Pharmaceutical, and Medical Devices and Diagnostics
segments, respectively. Includes $386 million of fourth quarter net litigation gain, comprised of a $92 million expense in the Pharmaceutical segment and a gain of $478 million in the
Medical Devices and Diagnostics segment.
(6) Includes $7 million and $174 million of IPR&D for the Consumer and Medical Devices and Diagnostics segments, respectively. Includes $379 million of fourth quarter net litigation gain,
comprised of a $50 million expense in the Consumer segment and a gain of $429 million in the Medical Devices and Diagnostics segment. The Medical Devices and Diagnostics segment
also includes $536 million gain on the divestiture of the Professional Wound Care business of Ethicon, Inc.
(7) Includes $745 million of restructuring expense, comprised of $15 million, $429 million, and $301 million for the Consumer, Pharmaceutical, and Medical Devices and Diagnostics segments,
respectively. The Medical Devices and Diagnostics segment includes $807 million of IPR&D. The Pharmaceutical segment also includes $678 million for the write-down of the NATRECOR®
intangible asset.
(8) Long-lived assets include property, plant and equipment, net for 2009, 2008 and 2007 of $14,759, $14,365 and $14,185, respectively, and intangible assets and goodwill, net for 2009,
2008 and 2007 of $31,185, $27,695 and $28,763, respectively.